Rebecca B Robertson's Net Worth

$736 Million

Estimate Recalculated Feb 26, 2024 07:04PM EST

Who is Rebecca B Robertson?

Rebecca B Robertson has an estimated net worth of $736 Million. This is based on reported shares across multiple companies, which include Inogen Inc, INTRALASE CORP, Alexza Pharmaceuticals Inc., AT ROAD INC, Flexion Therapeutics Inc, DIGITAL IMPACT INC /DE/, INSULET CORP, TANDEM DIABETES CARE INC, GLAUKOS Corp, SECOND SIGHT MEDICAL PRODUCTS INC, NOVACEA INC, PHASERX, INC., GENOMIC HEALTH INC, and HELICOS BIOSCIENCES CORP.

SEC CIK

Rebecca B Robertson's CIK is 0001201585

Past Insider Trading and Trends

2014 was Rebecca B Robertson's most active year for acquiring shares with 80 total transactions. Rebecca B Robertson's most active month to acquire stocks was the month of November. 2014 was Rebecca B Robertson's most active year for disposing of shares, totalling 50 transactions. Rebecca B Robertson's most active month to dispose stocks was the month of April. 2016 saw Rebecca B Robertson paying a total of $12,999,990.00 for 1,449,369 shares, this is the most they've acquired in one year. In 2003 Rebecca B Robertson cashed out on 3,352,758 shares for a total of $22,164,070.26, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Inogen Inc (INGN) Snapshot price: $7.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-11.28%
-384.69K
$24.30
-$179,534.67
3.03M
Nov 5 - Nov 7
Form 4
-35.10%
-735.77K
1.36M
Jan 6 - Jan 7
Form 4
-31.05%
-706.33K
1.57M
Jan 6 - Jan 7
Form 4
-100.00%
-7.95K
$30.98
-$246,159.13
0
Jan 5
Form 4
0
0
Form 4/A
-18.22%
-478.05K
2.15M
Dec 18
Form 4/A
-16.87%
-464.29K
2.29M
Dec 18
Form 4
-100.00%
-9.79K
$29.74
-$291,008.84
0
Dec 23
Form 4
0
0
Form 4
-18.22%
-478.05K
2.15M
Dec 18
Form 4
-16.87%
-464.29K
2.29M
Dec 18
Form 4
-11.64%
-5.34K
$24.89
-$132,961.62
40.57K
Nov 17
Form 4
-41.03%
-28.23K
$24.80
-$699,253.17
40.57K
Nov 17 - Nov 19
Form 4
-22.13%
-753.69K
$25.13
-$237,086.41
2.65M
Nov 12 - Nov 14
Form 4
-21.11%
-728.10K
$25.13
-$237,069.89
2.72M
Nov 12 - Nov 14
Form 4
-100.00%
-8.64K
$24.53
-$211,691.35
0
Nov 10
Form 4
-19.71%
-2.99K
$24.42
-$73,064.94
12.19K
Nov 10
Form 4
+4.31%
4.44K
$24.30
-$179,534.67
107.47K
Nov 5 - Nov 7
Form 4
+11.02%
14.47K
$24.30
-$179,534.67
145.72K
Nov 5 - Nov 7
Form 4
-100.00%
-4.65K
$20.76
-$96,455.46
0
Oct 24
Form 4
0
0
Form 4
-77.05%
-51.70K
15.4K
Oct 7
No matching records found

HELICOS BIOSCIENCES CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.32%
242.93K
$2.57
$625,012.88
10.71M
Sep 18
Form 4
+403.73%
8.62M
10.76M
Dec 23
Form 4
2.14M
$9.00
$999,999.00
2.14M
May 30
Form 3
0
0
No matching records found

INTRALASE CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.09M
2.09M
Oct 13
Form 3
0
0
No matching records found

Alexza Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.18M
2.18M
Mar 13
Form 3
0
0
No matching records found

Flexion Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.35%
714.28K
$14.00
$9,999,990.00
3.53M
Jun 8
Form 4
2.25K
$17.61
$39,622.50
2.25K
Sep 10
No matching records found